Stryker Corporation (LON: 0R2S)

Market Cap	110.55B
Revenue (ttm)	16.39B
Net Income (ttm)	2.68B
Shares Out	n/a
EPS (ttm)	6.96
PE Ratio	41.27
Forward PE	n/a
Dividend	2.49 (0.70%)
Ex-Dividend Date	Dec 31, 2024

Volume	582
Open	356.00
Previous Close	357.36
Day's Range	354.95 - 363.08
52-Week Range	250.79 - 363.08
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 28, 2025

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The ...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1941
• Employees: 52,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R2S

Financial Performance

In 2023, Stryker's revenue was $20.50 billion, an increase of 11.11% compared to the previous year's $18.45 billion. Earnings were $3.17 billion, an increase of 34.22%.

Financial numbers in USD